Prestige Consumer Healthcare (PBH) Change in Receivables (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Change in Receivables of -$495000.0 in Q4 2025, down 101.65% quarter-over-quarter from $29.9 million in Q3 2025, and down 107.84% on a YoY basis from $6.3 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Change in Receivables (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Change in Receivables history runs 16 years deep, the most recent figure standing at -$495000.0 for Q4 2025.
- In Q4 2025, Change in Receivables fell 107.84% year-over-year to -$495000.0; the TTM figure through Dec 2025 stood at $27.3 million (up 385.15% YoY), while the FY2025 annual figure was $16.3 million, up 158.26% from the prior year.
- Change in Receivables was -$495000.0 for Q4 2025 at Prestige Consumer Healthcare, down from $29.9 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $29.9 million in Q3 2025 to a low of -$27.3 million in Q2 2025.
- Historically, Change in Receivables has averaged $3.7 million across 5 years, with a median of $2.0 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables tumbled 824.98% in 2024, then soared 3726.04% in 2025.
- A 5-year view of Change in Receivables shows it stood at -$12.5 million in 2021, then jumped by 170.56% to $8.8 million in 2022, then rose by 29.88% to $11.4 million in 2023, then slumped by 44.74% to $6.3 million in 2024, then plunged by 107.84% to -$495000.0 in 2025.
- The last three Change in Receivables figures came in at -$495000.0 (Q4 2025), $29.9 million (Q3 2025), and -$27.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | -495,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -495,000.00 |
| Dec 31, 2025 | -495,000.00 |
| Sep 30, 2025 | 29.92 Mn |
| Sep 30, 2025 | 29.92 Mn |
| Jun 30, 2025 | -27.34 Mn |
| Jun 30, 2025 | -27.34 Mn |
| Mar 31, 2025 | 25.20 Mn |
| Mar 31, 2025 | 25.20 Mn |
| Dec 31, 2024 | 6.32 Mn |
| Dec 31, 2024 | 6.32 Mn |
| Sep 30, 2024 | -8.82 Mn |
| Sep 30, 2024 | -8.82 Mn |
| Jun 30, 2024 | -6.37 Mn |
| Jun 30, 2024 | -6.37 Mn |
| Mar 31, 2024 | -695,000.00 |
| Mar 31, 2024 | -695,000.00 |
| Dec 31, 2023 | 11.43 Mn |
| Dec 31, 2023 | 11.43 Mn |
| Sep 30, 2023 | 1.22 Mn |
| Sep 30, 2023 | 1.22 Mn |